Annual D&A:
$15.85M+$5.67M(+55.79%)Summary
- As of today, PCVX annual D&A is $15.85 million, with the most recent change of +$5.67 million (+55.79%) on December 31, 2024.
- During the last 3 years, PCVX annual D&A has risen by +$12.39 million (+358.35%).
- PCVX annual D&A is now at all-time high.
Performance
PCVX Depreciation & Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly D&A:
$4.99M+$115.00K(+2.36%)Summary
- As of today, PCVX quarterly D&A is $4.99 million, with the most recent change of +$115.00 thousand (+2.36%) on June 30, 2025.
- Over the past year, PCVX quarterly D&A has increased by +$1.51 million (+43.44%).
- PCVX quarterly D&A is now at all-time high.
Performance
PCVX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$19.14M+$1.51M(+8.57%)Summary
- As of today, PCVX TTM D&A is $19.14 million, with the most recent change of +$1.51 million (+8.57%) on June 30, 2025.
- Over the past year, PCVX TTM D&A has increased by +$7.14 million (+59.53%).
- PCVX TTM D&A is now at all-time high.
Performance
PCVX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
PCVX Depreciation & Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +55.8% | +43.4% | +59.5% |
| 3Y3 Years | +358.4% | +129.6% | +189.8% |
| 5Y5 Years | +1186.1% | +1305.3% | +1262.2% |
PCVX Depreciation & Amortization Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +358.4% | at high | +113.0% | at high | +136.2% |
| 5Y | 5-Year | at high | +1186.1% | at high | +1402.7% | at high | +1262.2% |
| All-Time | All-Time | at high | +1428.0% | at high | +1596.9% | at high | +6409.9% |
PCVX Depreciation & Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $4.99M(+2.4%) | $19.14M(+8.6%) |
| Mar 2025 | - | $4.87M(+1.9%) | $17.63M(+11.3%) |
| Dec 2024 | $15.85M(+55.8%) | $4.79M(+6.5%) | $15.85M(+13.1%) |
| Sep 2024 | - | $4.49M(+29.1%) | $14.01M(+16.8%) |
| Jun 2024 | - | $3.48M(+12.5%) | $12.00M(+9.9%) |
| Mar 2024 | - | $3.09M(+4.9%) | $10.92M(+7.4%) |
| Dec 2023 | $10.17M(+7.6%) | $2.95M(+18.9%) | $10.17M(+4.0%) |
| Sep 2023 | - | $2.48M(+3.3%) | $9.78M(+1.3%) |
| Jun 2023 | - | $2.40M(+2.5%) | $9.65M(+2.4%) |
| Mar 2023 | - | $2.34M(-8.4%) | $9.43M(-0.3%) |
| Dec 2022 | $9.45M | $2.56M(+8.6%) | $9.45M(+16.7%) |
| Sep 2022 | - | $2.35M(+8.3%) | $8.10M(+22.7%) |
| Jun 2022 | - | $2.17M(-8.3%) | $6.60M(+24.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $2.37M(+96.4%) | $5.30M(+53.3%) |
| Dec 2021 | $3.46M(+146.0%) | $1.21M(+40.9%) | $3.46M(+33.8%) |
| Sep 2021 | - | $856.00K(-1.4%) | $2.58M(+25.3%) |
| Jun 2021 | - | $868.00K(+64.7%) | $2.06M(+33.1%) |
| Mar 2021 | - | $527.00K(+58.7%) | $1.55M(+10.2%) |
| Dec 2020 | $1.41M(+14.0%) | $332.00K(-0.6%) | $1.41M(0.0%) |
| Sep 2020 | - | $334.00K(-5.9%) | $1.41M(+2.2%) |
| Jun 2020 | - | $355.00K(-7.6%) | $1.38M(+4.0%) |
| Mar 2020 | - | $384.00K(+15.7%) | $1.32M(+7.3%) |
| Dec 2019 | $1.23M(+18.8%) | $332.00K(+9.2%) | $1.23M(+36.9%) |
| Sep 2019 | - | $304.00K(+0.7%) | $900.00K(+51.0%) |
| Jun 2019 | - | $302.00K(+2.7%) | $596.00K(+102.7%) |
| Mar 2019 | - | $294.00K | $294.00K |
| Dec 2018 | $1.04M | - | - |
FAQ
- What is Vaxcyte, Inc. annual D&A?
- What is the all-time high annual D&A for Vaxcyte, Inc.?
- What is Vaxcyte, Inc. annual D&A year-on-year change?
- What is Vaxcyte, Inc. quarterly D&A?
- What is the all-time high quarterly D&A for Vaxcyte, Inc.?
- What is Vaxcyte, Inc. quarterly D&A year-on-year change?
- What is Vaxcyte, Inc. TTM D&A?
- What is the all-time high TTM D&A for Vaxcyte, Inc.?
- What is Vaxcyte, Inc. TTM D&A year-on-year change?
What is Vaxcyte, Inc. annual D&A?
The current annual D&A of PCVX is $15.85M
What is the all-time high annual D&A for Vaxcyte, Inc.?
Vaxcyte, Inc. all-time high annual D&A is $15.85M
What is Vaxcyte, Inc. annual D&A year-on-year change?
Over the past year, PCVX annual D&A has changed by +$5.67M (+55.79%)
What is Vaxcyte, Inc. quarterly D&A?
The current quarterly D&A of PCVX is $4.99M
What is the all-time high quarterly D&A for Vaxcyte, Inc.?
Vaxcyte, Inc. all-time high quarterly D&A is $4.99M
What is Vaxcyte, Inc. quarterly D&A year-on-year change?
Over the past year, PCVX quarterly D&A has changed by +$1.51M (+43.44%)
What is Vaxcyte, Inc. TTM D&A?
The current TTM D&A of PCVX is $19.14M
What is the all-time high TTM D&A for Vaxcyte, Inc.?
Vaxcyte, Inc. all-time high TTM D&A is $19.14M
What is Vaxcyte, Inc. TTM D&A year-on-year change?
Over the past year, PCVX TTM D&A has changed by +$7.14M (+59.53%)